Quarterly report pursuant to Section 13 or 15(d)

NOTE 11 - GOODWILL IMPAIRMENT LOSS (Details Narrative)

v3.3.0.814
NOTE 11 - GOODWILL IMPAIRMENT LOSS (Details Narrative) - Membership Interest Purchase Agreement
Sep. 29, 2014
USD ($)
$ / shares
shares
Percent of Aggregated amount of outstanding shares 50.00%
Stock options from purchase | shares 3,000,000
Percent of MardiMed outstanding shares 49.00%
Percent indirectly ownes of Sigal 100.00%
Percent owned of MariMed 51.00%
Common shares to be distributed | shares 31,954,236
Additional shares to purchase | shares 3,000,000
Price range - low $ 0.15
Price range - high $ 0.35
Fair value of common stock | $ $ 5,911,534
Approximate price per share $ 0.185
Black-Scholes valuation fair value of stock options | $ $ 569,682
Black-Scholes valuation, risk 1.56%
Black-Scholes valuation, dividend yield 0.00%
Black-Scholes valuation, volatility 311.00%